| 7/1/2018-12/31/2018 |
|
Advertising expenses
|
$0.00
|
| 7/1/2018-12/31/2018 |
|
Photocopies, scans
|
$0.00
|
| 7/1/2018-12/31/2018 |
|
Computer equipment, supplies
|
$0.00
|
| 7/1/2018-12/31/2018 |
|
Professional dues
|
$0.00
|
| 7/1/2018-12/31/2018 |
|
Fax charges
|
$0.00
|
| 7/1/2018-12/31/2018 |
|
Internet fees
|
$0.00
|
| 7/1/2018-12/31/2018 |
|
Legal fees
|
$0.00
|
| 7/1/2018-12/31/2018 |
|
Postage, shipping, delivery
|
$0.00
|
| 7/1/2018-12/31/2018 |
|
Office supplies, equipment
|
$0.00
|
| 7/1/2018-12/31/2018 |
|
Printing expenses
|
$0.00
|
| 7/1/2018-12/31/2018 |
|
Public relations expenses
|
$0.00
|
| 7/1/2018-12/31/2018 |
|
Rent
|
$0.00
|
| 7/1/2018-12/31/2018 |
|
Office and support staff salaries
|
$0.00
|
| 7/1/2018-12/31/2018 |
|
Professional subscriptions
|
$0.00
|
| 7/1/2018-12/31/2018 |
|
Taxes
|
$0.00
|
| 7/1/2018-12/31/2018 |
|
Telephone, cell phone, handheld
|
$0.00
|
| 7/1/2018-12/31/2018 |
|
Utilities (heat, water, electricity)
|
$0.00
|
| 7/1/2018-12/31/2018 |
|
Other operating expenses
|
$0.00
|
| | | Total operating expenses |
$0.00
|
|
|
Activities, Bill Numbers and Titles
|
|
|
|
Client: Boehringer Ingelheim Pharmaceuticals, Inc.
|
|
|
|
House Bill
|
1128
|
An Act relative to Diabetes prevention
|
Support
|
$900.00
|
N/A
|
|
House Bill
|
1228
|
An Act to promote transparency and cost control of pharmaceutical drug prices
|
Neutral
|
$1,800.00
|
N/A
|
|
Senate Bill
|
627
|
An Act to promote transparency in prescription drug prices
|
Neutral
|
$1,800.00
|
N/A
|
|
Senate Bill
|
652
|
An Act to promote transparency and prevent price gouging of pharmaceutical drug prices
|
Neutral
|
$1,800.00
|
N/A
|
|
House Bill
|
4825
|
An Act extending the authorization for the use of certain discount vouchers for prescription drugs
|
Support
|
$2,250.00
|
N/A
|
|
House Bill
|
1171
|
An Act to create a Massachusetts rare disease advisory council
|
Support
|
$1,350.00
|
N/A
|
|
Senate Bill
|
1163
|
An Act relative to transparency and access in healthcare
|
Neutral
|
$1,800.00
|
N/A
|
|
House Bill
|
3223
|
An Act to promote transparency in prescription drug prices
|
Neutral
|
$1,800.00
|
N/A
|
|
Senate Bill
|
2211
|
An Act furthering health empowerment and affordability by leveraging transformative health care.
|
Neutral
|
$2,250.00
|
N/A
|
| | | |
Total amount
|
$15,750.00
| |
|
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| No campaign contributions were filed for this disclosure reporting period. |
|